Having watched the action in this stock for years, and having listened to the statements from the FDA when they agreed to have another look at it, they're kind of telegraphing that they are going to be more forgiving this go-round. It was a close shave last time. This time, I absolutely believe it gets approved. 75% is conservative in my opinion, I'd say more like 85-90%. There's always the chance that in looking closer, something new and negative pops out, but I'd say that barring some bad findings this drug will hit the market in 2014.
I know Adam F comes across as an arrogant SOB, but I find he is right more often then not . . . and certainly has a better track record than 98% of all MB posters. His 75% chance of approval should be worth a few bucks appreciation over the next week or two IMHO.